British Columbia's Ministry of Health is limiting the sales of two more diabetes drugs to curb their off-label use for weight ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

Pointing to Ozempic as a paradigm shift, an elite rehab center is experimenting with GLP-1s to tame many forms of addiction.

Researchers have determined in a new study that the glucagon-like peptide-1 receptor agonists (GLP-1 RAs) lower the risk of ...

In a paper released in Addiction, scientists reported that people with a history of alcohol use disorder who were prescribed these medications were 50% less likely to binge drink. The results were ...

Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...

The use of semaglutide as treatment for obesity has skyrocketed over the last five years, which could mean major changes in how people spend and save.

In a small study, 14 people with type 2 diabetes tried the ReCET treatment. After the procedure, they followed a special diet ...

Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic dysfunction-associated steatohepatitis and moderate or advanced liver ...

In sum, Clinic Secret Semaglutide Reviews demonstrate that an affordable, medically supervised plan can deliver meaningful ...

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular events after just six months of starting the medication, a new study ...